The race to control pain: more participants, more targets
- 1 September 1999
- journal article
- current awareness
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 20 (9) , 354-357
- https://doi.org/10.1016/s0165-6147(99)01378-4
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- 3-Substituted GABA analogs with central nervous system activity: A reviewMedicinal Research Reviews, 1999
- Molecular Diversity of the Calcium Channel α2δ SubunitJournal of Neuroscience, 1999
- COX-2 inhibitorsThe Lancet, 1999
- The clinical use of tramadol hydrochloridePain Reviews, 1998
- The Effect of Intrathecal Gabapentin and 3-Isobutyl gamma-Aminobutyric Acid on the Hyperalgesia Observed After Thermal Injury in the RatAnesthesia & Analgesia, 1998
- Identification and Initial Structure−Activity Relationships of (R)-5-(2-Azetidinylmethoxy)-2-chloropyridine (ABT-594), a Potent, Orally Active, Non-Opiate Analgesic Agent Acting via Neuronal Nicotinic Acetylcholine ReceptorsJournal of Medicinal Chemistry, 1998
- SNX-111Drugs of the Future, 1998
- Gabapentin (neurontin) and S‐(+)‐3‐isobutylgaba represent a novel class of selective antihyperalgesic agentsBritish Journal of Pharmacology, 1997
- The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic painEuropean Journal of Pharmacology, 1997
- Epibatidine: Pharmacological Properties of a Novel Nicotinic Acetylcholine Receptor Agonist and Analgesic AgentCNS Drug Reviews, 1996